LivaNova (LIVN) Share-based Compensation Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 31.63% |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 6.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.26% |
| Dec 31, 2025 | 35.10% |
| Sep 30, 2025 | 16.22% |
| Jun 30, 2025 | 11.89% |
| Mar 31, 2025 | -23.89% |
| Dec 31, 2024 | -16.11% |
| Sep 30, 2024 | -27.34% |
| Jun 30, 2024 | 43.57% |
| Mar 31, 2024 | -3.34% |
| Dec 31, 2023 | -32.75% |
| Sep 30, 2023 | 9.81% |
| Jun 30, 2023 | -50.38% |
| Mar 31, 2023 | 3.15% |
| Dec 31, 2022 | 23.29% |
| Sep 30, 2022 | -3.55% |
| Jun 30, 2022 | 16.06% |
| Mar 31, 2022 | 7.55% |
| Dec 31, 2021 | 21.18% |
| Sep 30, 2021 | 42.39% |
| Jun 30, 2021 | -0.75% |
| Mar 31, 2021 | 5.45% |
| Dec 31, 2020 | -2.16% |
| Sep 30, 2020 | -8.44% |
| Jun 30, 2020 | 14.52% |
| Mar 31, 2020 | 31.59% |
| Dec 31, 2019 | 52.20% |
| Sep 30, 2019 | 19.03% |
| Jun 30, 2019 | 15.70% |
| Mar 31, 2019 | 2.87% |
| Dec 31, 2018 | 15.09% |
| Sep 30, 2018 | 26.00% |
| Jun 30, 2018 | 59.75% |
| Mar 31, 2018 | 73.78% |
| Dec 31, 2017 | 20.43% |
| Sep 30, 2017 | 19.30% |
| Mar 31, 2017 | -37.15% |